A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00111189
Recruitment Status : Completed
First Posted : May 18, 2005
Last Update Posted : June 20, 2014
Janssen-Cilag International NV
Information provided by (Responsible Party):
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.